- Nachrichtendetail
-
18.06.2024 08:06:48 - dpa-AFX: *ASTRAZENECA SAYS CAPITELLO-290 PHASE III TRIAL FOR TRUQAP + CHEMOTHERAPY FAILS TO MEET DUAL PRIMARY ENDPOINTS OF IMPROVEMENT IN OVERALL SURVIVAL
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ASTRAZENECA PLC DL-,25 | 886455 | Xetra | 145,750 | 27.06.24 17:35:44 | -2,700 | -1,82% | 0,000 | 0,000 | 148,200 | 148,450 |
